BE857014R - Preparation de vaccins a base d'acides nucleiques arn associes a des polysaccharides extraits de germes microbiens. - Google Patents

Preparation de vaccins a base d'acides nucleiques arn associes a des polysaccharides extraits de germes microbiens.

Info

Publication number
BE857014R
BE857014R BE179522A BE179522A BE857014R BE 857014 R BE857014 R BE 857014R BE 179522 A BE179522 A BE 179522A BE 179522 A BE179522 A BE 179522A BE 857014 R BE857014 R BE 857014R
Authority
BE
Belgium
Prior art keywords
preparation
nucleic acids
vaccines based
rna nucleic
acids associated
Prior art date
Application number
BE179522A
Other languages
English (en)
French (fr)
Inventor
L Dussourd D Hinterland
G Normier
A M Pinel
J Durand
Original Assignee
Fabre Sa Pierre
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fabre Sa Pierre filed Critical Fabre Sa Pierre
Application granted granted Critical
Publication of BE857014R publication Critical patent/BE857014R/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/09Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092Streptococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/025Enterobacteriales, e.g. Enterobacter
    • A61K39/0266Klebsiella
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/05Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/102Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55572Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/70Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
BE179522A 1976-08-06 1977-07-20 Preparation de vaccins a base d'acides nucleiques arn associes a des polysaccharides extraits de germes microbiens. BE857014R (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7624124A FR2360314A2 (fr) 1976-08-06 1976-08-06 Nouveaux vaccins perfectionnes a base de fractions ribosomales

Publications (1)

Publication Number Publication Date
BE857014R true BE857014R (fr) 1978-01-20

Family

ID=9176646

Family Applications (1)

Application Number Title Priority Date Filing Date
BE179522A BE857014R (fr) 1976-08-06 1977-07-20 Preparation de vaccins a base d'acides nucleiques arn associes a des polysaccharides extraits de germes microbiens.

Country Status (9)

Country Link
JP (1) JPS5320418A (enrdf_load_stackoverflow)
AU (1) AU511331B2 (enrdf_load_stackoverflow)
BE (1) BE857014R (enrdf_load_stackoverflow)
CA (1) CA1087093A (enrdf_load_stackoverflow)
DE (1) DE2735411C2 (enrdf_load_stackoverflow)
ES (1) ES461415A2 (enrdf_load_stackoverflow)
FR (1) FR2360314A2 (enrdf_load_stackoverflow)
GB (1) GB1590144A (enrdf_load_stackoverflow)
ZA (1) ZA774733B (enrdf_load_stackoverflow)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4293545A (en) 1980-03-31 1981-10-06 Norden Laboratories, Inc. Modified Pasteurella multocida bacteria vaccines
US4328210A (en) 1980-03-31 1982-05-04 Norden Laboratories, Inc. Modified Pasteurella bacteria and vaccines prepared therefrom
US4335106A (en) 1980-03-31 1982-06-15 Norden Laboratories Inc. Processes for the growth of a modified Pasteurella multocida bacteria and preparation of a vaccine therefrom
US4388299A (en) 1980-03-31 1983-06-14 Norden Laboratories, Inc. Modified pasteurella bacteria and vaccines prepared therefrom
US4506017A (en) * 1981-04-17 1985-03-19 Norden Laboratories, Inc. Modified Pasteurella haemolytica bacteria
US4559306A (en) * 1981-04-17 1985-12-17 Norden Laboratories, Inc. Modified Pasteurella multocida bacteria
US4626430A (en) * 1981-04-17 1986-12-02 Norden Laboratories, Inc. Processes for growth of modified Pasteurella haemolytica bacteria and preparation of a vaccine therefrom
WO2002053189A3 (en) * 2001-01-06 2003-11-20 Benedikt Timmerman Immunogenic complex

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4346074A (en) * 1978-08-24 1982-08-24 National Research Development Corp. Pasteurellosis vaccines
JPS55106066U (enrdf_load_stackoverflow) * 1979-01-19 1980-07-24
JPS639754Y2 (enrdf_load_stackoverflow) * 1979-01-25 1988-03-23
FR2471785A1 (fr) 1979-12-21 1981-06-26 Fabre Sa Pierre Preparations immunostimulantes a base d'arn ribosomaux et procede de preparation des arn
FR2475900A1 (fr) * 1980-02-20 1981-08-21 Fabre Sa Pierre Complexe vaccinal contenant un antigene specifique et vaccin le contenant
JPS58191628A (ja) * 1982-05-04 1983-11-08 Aisin Seiki Co Ltd 車輌ル−フパネル開閉装置
JPS626614A (ja) * 1985-07-03 1987-01-13 株式会社チノー 温室の天窓制御装置
JPS62104526A (ja) * 1985-10-30 1987-05-15 株式会社チノー 温室の制御装置
FR2596064B1 (fr) * 1986-03-18 1990-02-02 Pf Medicament Procedes industriels de fabrication de vaccins ribosomaux et vaccins ribosomaux obtenus
DE19703437A1 (de) * 1997-01-30 1998-08-06 Luitpold Pharma Gmbh Gemische äußerer Membranen und/oder Zellwände von Bakterien zur oralen Immunisierung gegen Schleimhautinfektionen

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51142528A (en) * 1975-05-19 1976-12-08 Fabre Sa Pierre Production of vaccine based on antigenic libosome fractionation

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4293545A (en) 1980-03-31 1981-10-06 Norden Laboratories, Inc. Modified Pasteurella multocida bacteria vaccines
US4328210A (en) 1980-03-31 1982-05-04 Norden Laboratories, Inc. Modified Pasteurella bacteria and vaccines prepared therefrom
US4335106A (en) 1980-03-31 1982-06-15 Norden Laboratories Inc. Processes for the growth of a modified Pasteurella multocida bacteria and preparation of a vaccine therefrom
US4388299A (en) 1980-03-31 1983-06-14 Norden Laboratories, Inc. Modified pasteurella bacteria and vaccines prepared therefrom
US4506017A (en) * 1981-04-17 1985-03-19 Norden Laboratories, Inc. Modified Pasteurella haemolytica bacteria
US4559306A (en) * 1981-04-17 1985-12-17 Norden Laboratories, Inc. Modified Pasteurella multocida bacteria
US4626430A (en) * 1981-04-17 1986-12-02 Norden Laboratories, Inc. Processes for growth of modified Pasteurella haemolytica bacteria and preparation of a vaccine therefrom
WO2002053189A3 (en) * 2001-01-06 2003-11-20 Benedikt Timmerman Immunogenic complex

Also Published As

Publication number Publication date
JPS5320418A (en) 1978-02-24
ZA774733B (en) 1978-07-26
FR2360314A2 (fr) 1978-03-03
AU2753877A (en) 1979-02-08
DE2735411C2 (de) 1982-07-29
GB1590144A (en) 1981-05-28
DE2735411A1 (de) 1978-02-09
FR2360314B2 (enrdf_load_stackoverflow) 1980-04-25
ES461415A2 (es) 1978-07-16
CA1087093A (en) 1980-10-07
AU511331B2 (en) 1980-08-14

Similar Documents

Publication Publication Date Title
BE857014R (fr) Preparation de vaccins a base d'acides nucleiques arn associes a des polysaccharides extraits de germes microbiens.
BE878430A (fr) Vaccins contre la pasteurellose
BE858992A (fr) Procede de preparation de vaccins
FI883763L (fi) Frigoering av vaerdens foersvarsmediatorer i biologiska vaetskor genom systematisk behandling med dubbelstraengat rna.
FR2315947A1 (fr) Vaccin contre l'hepatite b
IT7924256A0 (it) Riscaldatore per acquario.
NL7804660A (nl) Verbeterde vaccins.
CA1004454A (en) Earth's magnetic field sensor
NO881288D0 (no) Pasteurella-vaksine.
BE839893A (fr) Preparation de vaccins a base d'acides nucleiques arn associes a des polysaccharides extraits de germes microbiens.
NO810853L (no) Magnetisk kontrollert legemiddel-infusjonssystem.
DE3851907D1 (de) Aliphatische Carboxamide.
AU505999B2 (en) Hepatitis vaccine
FR2651505B1 (fr) Fragments d'acides nucleiques derives d'un genome de mycobacterie appropriee, leurs applications dans le diagnostic des infections a mycobacteries et plasmides contenant lesdits fragments.
USD243540S (en) Aquarium
NL7805801A (nl) Magneetkop.
NL7709085A (nl) Vaccins.
IT7831198A0 (it) Derivato isossazolico,ad attivita'terapeutica
NL7409842A (nl) Vaccin tegen de ziekte van marek.
FR2313926A1 (fr) 4-phenyl-imidazolines substituees, leurs sels d'addition avec des acides et procedes pour leur preparation
Devrome The Metis: colonization, culture change and the Saskatchewan Rebellion of 1885
SU574598A2 (ru) Теплообменна труба
IT1093675B (it) Girante di soffiante,specialmente per soffiante per l'aria di combustione
BE832268A (fr) Derives d'hydrazobenzene et leur preparation.
Daniel Effect of conformation on bovine muscle yield

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: PF MEDICAMENT S.A.

Effective date: 19960322